This article evaluates the most up-to-date peer-reviewed published work on the treatment of peripheral T-cell lymphoma, and offers a glimpse into the current upfront clinical trial landscape for patients affected by this uncommon disease.
|Original language||English (US)|
|Journal||ONCOLOGY (United States)|
|State||Published - Aug 15 2015|
ASJC Scopus subject areas
- Cancer Research